You are here

R&D

U.S. payer pressures force Novo Nordisk to cut loose 1,000 staffers

Fierce Pharma

Thu, 09/29/16 - 08:25 am

Amgen and Arrowhead to develop gene-therapies for heart disease

Yahoo/Reuters

Thu, 09/29/16 - 08:18 am

Sanofi grabs $43M in U.S. government funds to advance Zika vaccine into Phase II

Fierce Pharma

Tue, 09/27/16 - 10:55 am

Diabetes drugs are badly needed, but rarely make it to market

Stat/Pharmalot

Tue, 09/27/16 - 09:46 am

clinical trials

Pfizer won’t split into two companies, so what’s next?

Stat

Mon, 09/26/16 - 03:21 pm

Gilead Sciences: Another Blow to R&D Strategy

Barron's

Fri, 09/23/16 - 10:06 pm

Gilead Sciences

ulcerative colitis

Arena Launches Drug Discovery Incubator (ARNA)

Investopedia

Mon, 09/19/16 - 06:02 pm

Arena Pharmaceuticals

Beacon Discovery

Eisai launches research division in Massachusetts aimed at Alzheimer’s, I/O and autoimmune diseases

Endpoints

Thu, 09/15/16 - 09:29 am

Alzheimer's disease

autoimmune disease

Takeda will transfer 300 staffers to CRO in ongoing R&D overhaul

Endpoints

Tue, 09/13/16 - 12:56 pm

Neuralstem Receives $20,000,000 Strategic Investment from Tianjin Pharmaceutical Group

Yahoo

Mon, 09/12/16 - 09:32 am

Tianjin Pharmaceutical

Circle Pharma Enters into an Agreement with Pfizer to Build Screening Library of Macrocyclic Peptides

Yahoo

Mon, 09/12/16 - 09:25 am

macrocyclic peptides

Arena to focus on R&D with new spinout and old candidates

Fierce Biotech

Mon, 09/5/16 - 10:12 am

Arena Pharmaceuticals

Beacon Discovery

In wake of generics deal, Teva to close New York plant

BioPharma Dive

Thu, 09/1/16 - 04:44 pm

Teva Pharmaceutical

drug manufacturing

Medivir plans year-end split

BioPharma Dive

Thu, 09/1/16 - 09:21 am

Scoop: Novartis disbands its pioneering cell and gene therapy unit

Endpoints

Wed, 08/31/16 - 09:24 am

Drug Development Is Lagging For The World's Leading Killer

Forbes

Tue, 08/30/16 - 10:03 am

cardiovascular disease

Booming Moderna is raising $600M while ramping up manufacturing and clinical studies

Endpoints

Mon, 08/29/16 - 09:10 am

Moderna Therapeutics

Biotech Exec Miralles Describes Living In Translation

Forbes

Thu, 08/25/16 - 09:41 am

Adaptive Biotechnologies

Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D

Endpoints

Wed, 08/24/16 - 10:58 am

Lou Gehrig's disease

Life After Martin Shkreli -- A Conversation With Turing Pharmaceutical's R&D Head

Forbes

Wed, 08/24/16 - 10:45 am

Turing Pharmaceuticals

Pages